177 related articles for article (PubMed ID: 35605246)
1. Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy.
Hasan AN; Doubrovina E; Sottile R; Prockop S; Klatt MG; Heller G; Selvakumar A; Barnett L; Hsu KC; O'Reilly RJ
Blood Adv; 2022 Aug; 6(16):4859-4872. PubMed ID: 35605246
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia.
Koehne G; Hasan A; Doubrovina E; Prockop S; Tyler E; Wasilewski G; O'Reilly RJ
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1663-78. PubMed ID: 26028505
[TBL] [Abstract][Full Text] [Related]
3. Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant.
Prockop SE; Hasan A; Doubrovina E; Dahi PB; Rodriguez-Sanchez I; Curry M; Mauguen A; Papanicolaou GA; Su Y; Yao J; Arcila M; Boulad F; Castro-Malaspina H; Cho C; Curran KJ; Giralt S; Kernan NA; Koehne G; Jakubowski A; Papadopoulos E; Perales MA; Politikos I; Price K; Selvakumar A; Sauter CS; Tamari R; Vizconde T; Young JW; O'Reilly RJ
J Clin Invest; 2023 May; 133(10):. PubMed ID: 36951958
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
5. A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.
Hasan AN; Kollen WJ; Trivedi D; Selvakumar A; Dupont B; Sadelain M; O'Reilly RJ
J Immunol; 2009 Aug; 183(4):2837-50. PubMed ID: 19635907
[TBL] [Abstract][Full Text] [Related]
6. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
Paine A; Oelke M; Tischer S; Heuft HG; Blasczyk R; Eiz-Vesper B
J Immunother; 2010 Jan; 33(1):60-72. PubMed ID: 19952955
[TBL] [Abstract][Full Text] [Related]
7. Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles.
Lacey SF; Villacres MC; La Rosa C; Wang Z; Longmate J; Martinez J; Brewer JC; Mekhoubad S; Maas R; Leedom JM; Forman SJ; Zaia JA; Diamond DJ
Hum Immunol; 2003 Apr; 64(4):440-52. PubMed ID: 12651070
[TBL] [Abstract][Full Text] [Related]
8. Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy.
Trivedi D; Williams RY; O'Reilly RJ; Koehne G
Blood; 2005 Apr; 105(7):2793-801. PubMed ID: 15514011
[TBL] [Abstract][Full Text] [Related]
9. Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.
Chikata T; Paes W; Akahoshi T; Partridge T; Murakoshi H; Gatanaga H; Ternette N; Oka S; Borrow P; Takiguchi M
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217245
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals.
Ventura C; Bisceglia H; Girerd-Chambaz Y; Burdin N; Chaux P
J Clin Immunol; 2012 Dec; 32(6):1305-16. PubMed ID: 22797815
[TBL] [Abstract][Full Text] [Related]
11. Immune control in the absence of immunodominant epitopes: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.
Ebert S; Lemmermann NA; Thomas D; Renzaho A; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2012 Nov; 201(4):541-50. PubMed ID: 22976556
[TBL] [Abstract][Full Text] [Related]
12. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a cell donor registry for virus-specific T cell manufacture in a blood bank.
Rudilla F; Carrasco-Benso MP; Pasamar H; López-Montañés M; Andrés-Rozas M; Tomás-Marín M; Company D; Moya C; Larrea L; Guerreiro M; Barba P; Arbona C; Querol S
HLA; 2024 Mar; 103(3):e15419. PubMed ID: 38450972
[TBL] [Abstract][Full Text] [Related]
14. Human CD8+ T cells from TB pleurisy respond to four immunodominant epitopes in Mtb CFP10 restricted by HLA-B alleles.
Li L; Yang B; Yu S; Zhang X; Lao S; Wu C
PLoS One; 2013; 8(12):e82196. PubMed ID: 24349220
[TBL] [Abstract][Full Text] [Related]
15. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
16. HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy.
Chen FE; Aubert G; Travers P; Dodi IA; Madrigal JA
Cytotherapy; 2002; 4(1):41-8. PubMed ID: 11953040
[TBL] [Abstract][Full Text] [Related]
17. Recombinant MHC Tetramers for Isolation of Virus-Specific CD8
Vdovin AS; Filkin SY; Yefimova PR; Sheetikov SA; Kapranov NM; Davydova YO; Egorov ES; Khamaganova EG; Drokov MY; Kuzmina LA; Parovichnikova EN; Efimov GA; Savchenko VG
Biochemistry (Mosc); 2016 Nov; 81(11):1371-1383. PubMed ID: 27914462
[TBL] [Abstract][Full Text] [Related]
18. Artificial antigen presenting cells that express prevalent HLA alleles: A step towards the broad application of antigen-specific adoptive cell therapies.
Hasan AN; Selvakumar A; Doubrovina E; Riviere I; Sadelain MW; O'Reilly RJ
Discov Med; 2009 Dec; 8(43):210-8. PubMed ID: 20040272
[TBL] [Abstract][Full Text] [Related]
19. Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection.
Tischer S; Geyeregger R; Kwoczek J; Heim A; Figueiredo C; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
J Transl Med; 2016 Oct; 14(1):286. PubMed ID: 27717382
[TBL] [Abstract][Full Text] [Related]
20. Convergent clonal selection of donor- and recipient-derived CMV-specific T cells in hematopoietic stem cell transplant patients.
Erickson JR; Stevens-Ayers T; Mair F; Edmison B; Boeckh M; Bradley P; Prlic M
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35105810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
